Source:http://linkedlifedata.com/resource/pubmed/id/12220847
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-9-10
|
pubmed:abstractText |
A new cationic polymer (PPA-SP), polyphosphoramidate bearing spermidine side chain, was prepared as a non-viral vector for gene delivery. PPA-SP was synthesized from poly(1,2-propylene H-phosphonate) by the Atherton-Todd reaction. The weight average molecular weight of PPA-SP was 3.44x10(4) with a number average degree of polymerization of 90, as determined by GPC/LS/RI method. The average net positive charge per polymer chain was 102. PPA-SP was able to condense plasmid DNA efficiently and formed complexes at an N/P ratio (free amino groups in polymer to phosphate groups in DNA) of 2 and above, as determined by agarose gel electrophoresis. This new gene carrier offered significant protection to DNA against nuclease degradation at N/P ratios above 2, and showed lower cytotoxicity than PLL and PEI in cell culture. The LD(50) of PPA-SP was 85 microg/ml in COS-7 cells, in contrast to 20 and 42 microg/ml for PLL and PEI, respectively. The complexes prepared in saline at N/P ratios of 5 approximately 10 had an average size of 250 nm and zeta-potential of 26 mV. PPA-SP mediated efficient gene transfection in a number of cell lines, and the transfection protocol was optimized in HEK293 cells using a luciferase plasmid as a marker gene. Gene expression mediated by PPA-SP was greatly enhanced when chloroquine was used in conjunction at a concentration of 100 microM. Under the optimized condition, PPA-SP/DNA complexes yield a luciferase expression level closed to PEI/DNA complexes or Transfast mediated transfection. In a non-invasive CNS gene delivery model, PPA-SP/DNA complexes yielded comparable bcl-2 expression as PEI/DNA complexes in mouse brain stem following injection of the complexes in the tongue.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0168-3659
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2002 Elsevier Science B.V.
|
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
157-68
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12220847-Animals,
pubmed-meshheading:12220847-COS Cells,
pubmed-meshheading:12220847-Cercopithecus aethiops,
pubmed-meshheading:12220847-Drug Carriers,
pubmed-meshheading:12220847-Female,
pubmed-meshheading:12220847-Gene Therapy,
pubmed-meshheading:12220847-Humans,
pubmed-meshheading:12220847-Mice,
pubmed-meshheading:12220847-Mice, Inbred BALB C,
pubmed-meshheading:12220847-Polymers,
pubmed-meshheading:12220847-Spermidine,
pubmed-meshheading:12220847-Tumor Cells, Cultured
|
pubmed:year |
2002
|
pubmed:articleTitle |
New polyphosphoramidate with a spermidine side chain as a gene carrier.
|
pubmed:affiliation |
Johns Hopkins Singapore Biomedical Centre, Tissue and Therapeutic Engineering Laboratory, 10 Medical Drive, Singapore 117597, Singapore.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|